Abstract: Several high-profile examples of research misconduct have recently come to light, amidst waning public trust in science. The issues are not new, although there are now novel tools for identifying misconduct, proliferating platforms for discussing allegations and publicizing concerns, and growing unease about politically motivated misconduct allegations. In addition, the US Department of Health and Human Services Office of Research Integrity recently proposed new regulations to revise the Public Health Service Policies on Research Misconduct, with a final rule expected this year.
   Against this backdrop, how should institutional stakeholders – including universities and publishers – address concerns about research misconduct, from prevention to response? This symposium will present commentaries on these issues from leading experts in ethics and law, those with experience identifying research misconduct, and those sharing relevant stakeholder perspectives, including researchers, academic leadership, and journal editors and publishers.

Symposium agenda

University of Pennsylvania Department of Medical Ethics & Health Policy and the Institute for Translational Medicine and Therapeutics